Unicycive Therapeutics | 4:持股變動聲明-高管 Gupta Shalabh K.
Unicycive Therapeutics | 4:持股變動聲明-高管 Gupta Pramod
Unicycive Therapeutics | 4:持股變動聲明-高管 Jermasek Douglas
Unicycive Therapeutics | 4:持股變動聲明-高管 Townsend John
Unicycive Therapeutics | D:發行公告
Unicycive Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-RA Capital Management, L.P.(9.99%),Peter Kolchinsky(9.99%)等
Unicycive Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Nantahala Capital Management, LLC(9.9%),Wilmot B. Harkey(9.9%)等
Unicycive Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Armistice Capital, LLC(2.73%),Steven Boyd(2.73%)
Unicycive Therapeutics | SC 13G:超過5%持股股東披露文件-NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP(6.1%)
Unicycive Therapeutics | SC 13G:超過5%持股股東披露文件-Logos Global Management LP(9.9%),Logos Global Management GP LLC(9.9%)等
Unicycive Therapeutics | 4:持股變動聲明-董事 Laumas Sandeep
Unicycive Therapeutics | 4:持股變動聲明-董事 Kenkare-Mitra Sara
Unicycive Therapeutics | 4:持股變動聲明-董事 Ryan John L
Unicycive Therapeutics | 4:持股變動聲明-董事 Aggarwal Gaurav
Unicycive Therapeutics | 3:首次持股聲明-董事 Kenkare-Mitra Sara
Unicycive Therapeutics | 4:持股變動聲明-高管 Gupta Pramod
Unicycive Therapeutics | 4:持股變動聲明-首席執行官 Gupta Shalabh K.
Unicycive Therapeutics | 4:持股變動聲明-首席財務官 Townsend John
Unicycive Therapeutics | 4:持股變動聲明-高管 Jermasek Douglas
Unicycive Therapeutics | SC 13G:超過5%持股股東披露文件-Vivo Opportunity Fund Holdings, L.P.(9.99%),Vivo Opportunity, LLC(9.99%)
暫無數據